122 related articles for article (PubMed ID: 15760341)
1. Degradation of tyrosinase induced by phenylthiourea occurs following Golgi maturation.
Hall AM; Orlow SJ
Pigment Cell Res; 2005 Apr; 18(2):122-9. PubMed ID: 15760341
[TBL] [Abstract][Full Text] [Related]
2. Structural requirement of phenylthiourea analogs for their inhibitory activity of melanogenesis and tyrosinase.
Thanigaimalai P; Lee KC; Sharma VK; Joo C; Cho WJ; Roh E; Kim Y; Jung SH
Bioorg Med Chem Lett; 2011 Nov; 21(22):6824-8. PubMed ID: 21978680
[TBL] [Abstract][Full Text] [Related]
3. 25-hydroxycholesterol acts in the Golgi compartment to induce degradation of tyrosinase.
Hall AM; Krishnamoorthy L; Orlow SJ
Pigment Cell Res; 2004 Aug; 17(4):396-406. PubMed ID: 15250942
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tyrosinase reduces cell viability in catecholaminergic neuronal cells.
Higashi Y; Asanuma M; Miyazaki I; Ogawa N
J Neurochem; 2000 Oct; 75(4):1771-4. PubMed ID: 10987861
[TBL] [Abstract][Full Text] [Related]
5. Long-term suppression of tyrosinase by terrein via tyrosinase degradation and its decreased expression.
Park SH; Kim DS; Lee HK; Kwon SB; Lee S; Ryoo IJ; Kim WG; Yoo ID; Park KC
Exp Dermatol; 2009 Jun; 18(6):562-6. PubMed ID: 19493001
[TBL] [Abstract][Full Text] [Related]
6. Coumestrol Down-Regulates Melanin Production in Melan-a Murine Melanocytes through Degradation of Tyrosinase.
Hwang JA; Park NH; Na YJ; Lee HK; Lee JH; Kim YJ; Lee CS
Biol Pharm Bull; 2017; 40(4):535-539. PubMed ID: 28381809
[TBL] [Abstract][Full Text] [Related]
7. Analogues of N-hydroxy-N'-phenylthiourea and N-hydroxy-N'-phenylurea as inhibitors of tyrosinase and melanin formation.
Criton M; Le Mellay-Hamon V
Bioorg Med Chem Lett; 2008 Jun; 18(12):3607-10. PubMed ID: 18501598
[TBL] [Abstract][Full Text] [Related]
8. Intracellular composition of fatty acid affects the processing and function of tyrosinase through the ubiquitin-proteasome pathway.
Ando H; Wen ZM; Kim HY; Valencia JC; Costin GE; Watabe H; Yasumoto K; Niki Y; Kondoh H; Ichihashi M; Hearing VJ
Biochem J; 2006 Feb; 394(Pt 1):43-50. PubMed ID: 16232122
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of 16-hydroxy-9-oxo-10E,12E,14E-octadecatrienoic acid (Corchorifatty acid B) isolated from Melissa officinalis Linné on melanogenesis.
Fujita H; Hongo M; Mochizuki M; Yokoyama K; Tanaka Y
Exp Dermatol; 2011 May; 20(5):420-4. PubMed ID: 21410768
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of Asterina pectinifera extracts on melanin biosynthesis through tyrosinase activity.
Jeong MH; Yang KM; Kim JK; Nam BH; Kim GY; Lee SW; Seo SY; Jo WS
Int J Mol Med; 2013 Jan; 31(1):205-12. PubMed ID: 23151809
[TBL] [Abstract][Full Text] [Related]
11. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells.
Halaban R; Cheng E; Zhang Y; Moellmann G; Hanlon D; Michalak M; Setaluri V; Hebert DN
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6210-5. PubMed ID: 9177196
[TBL] [Abstract][Full Text] [Related]
12. L-tyrosine, L-dopa, and tyrosinase as positive regulators of the subcellular apparatus of melanogenesis in Bomirski Ab amelanotic melanoma cells.
Slominski A; Moellmann G; Kuklinska E
Pigment Cell Res; 1989; 2(2):109-16. PubMed ID: 2497448
[TBL] [Abstract][Full Text] [Related]
13. Exploring the interaction of N/S compounds with a dicopper center: tyrosinase inhibition and model studies.
Buitrago E; Vuillamy A; Boumendjel A; Yi W; Gellon G; Hardré R; Philouze C; Serratrice G; Jamet H; Réglier M; Belle C
Inorg Chem; 2014 Dec; 53(24):12848-58. PubMed ID: 25415587
[TBL] [Abstract][Full Text] [Related]
14. Fine structural demonstration of tyrosinase activity in the retinal pigment epithelium of normal and PTU-treated chick embryos.
Mishima H; Hasebe H; Kondo K; Fujita H
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Jul; 211(1):1-10. PubMed ID: 111576
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors.
Ha YM; Park YJ; Kim JA; Park D; Park JY; Lee HJ; Lee JY; Moon HR; Chung HY
Eur J Med Chem; 2012 Mar; 49():245-52. PubMed ID: 22301213
[TBL] [Abstract][Full Text] [Related]
16. (-)-N-Formylanonaine from Michelia alba as a human tyrosinase inhibitor and antioxidant.
Wang HM; Chen CY; Chen CY; Ho ML; Chou YT; Chang HC; Lee CH; Wang CZ; Chu IM
Bioorg Med Chem; 2010 Jul; 18(14):5241-7. PubMed ID: 20584613
[TBL] [Abstract][Full Text] [Related]
17. Modeling the met form of human tyrosinase: a refined and hydrated pocket for antagonist design.
Favre E; Daina A; Carrupt PA; Nurisso A
Chem Biol Drug Des; 2014 Aug; 84(2):206-15. PubMed ID: 24612747
[TBL] [Abstract][Full Text] [Related]
18. Partially purified components of Nardostachys chinensis suppress melanin synthesis through ERK and Akt signaling pathway with cAMP down-regulation in B16F10 cells.
Jang JY; Kim HN; Kim YR; Choi WY; Choi YH; Shin HK; Choi BT
J Ethnopharmacol; 2011 Oct; 137(3):1207-14. PubMed ID: 21816215
[TBL] [Abstract][Full Text] [Related]
19. Approaches to identify inhibitors of melanin biosynthesis via the quality control of tyrosinase.
Ando H; Kondoh H; Ichihashi M; Hearing VJ
J Invest Dermatol; 2007 Apr; 127(4):751-61. PubMed ID: 17218941
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of 2-(substituted phenyl)thiazolidine-4-carboxylic acid derivatives as novel tyrosinase inhibitors.
Ha YM; Park YJ; Lee JY; Park D; Choi YJ; Lee EK; Kim JM; Kim JA; Park JY; Lee HJ; Moon HR; Chung HY
Biochimie; 2012 Feb; 94(2):533-40. PubMed ID: 21945595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
